Sep 12, 2022 | Business News, Investor News
Development Bank of Wales ramping up tech equity deals since the lockdown Posted on September 12, 2022 The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most promising tech-focused start-ups over a ten week period since the pandemic...
Aug 8, 2022 | Business News, Milestones
Reacta Healthcare secures first US patent Posted on August 8, 2022 The patent has been granted for challenge meals, which are used in oral food challenges (OFCs). Unique to the Reacta formulation is Reacta’s ability to create a non-allergen formulation that is...
Apr 27, 2022 | Business News, Investor News
Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics Posted on April 27, 2022 The £1 million grant will support the development of the first Oral Food Challenges (OFCs) for paediatric patients to diagnose...
Apr 22, 2022 | Business News, Milestones
UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA GMP licence Posted on June 16, 2021 Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an MHRA site license This license opens up significant opportunities for the companies...
Jul 14, 2021 | Business News, Investor News
Praetura Ventures leads £2.9m investment in food allergy diagnostic firm Posted on July 14, 2021 Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a business that is on course to transform the food allergy diagnostics market....
